Development of high-throughput quantitative assays for glucose uptake in cancer cell lines.
OBJECTIVE
Metabolism, and especially glucose uptake, is a key quantitative cell trait that is closely linked to cancer initiation and progression. Therefore, developing high-throughput assays for measuring glucose uptake in cancer cells would be enviable for simultaneous comparisons of multiple cell lines and microenvironmental conditions. This study was designed with two specific aims in mind: the first was to develop and validate a high-throughput screening method for quantitative assessment of glucose uptake in "normal" and tumor cells using the fluorescent 2-deoxyglucose analog 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose (2-NBDG), and the second was to develop an image-based, quantitative, single-cell assay for measuring glucose uptake using the same probe to dissect the full spectrum of metabolic variability within populations of tumor cells in vitro in higher resolution.


METHODS
The kinetics of population-based glucose uptake was evaluated for MCF10A mammary epithelial and CA1d breast cancer cell lines, using 2-NBDG and a fluorometric microplate reader. Glucose uptake for the same cell lines was also examined at the single-cell level using high-content automated microscopy coupled with semi-automated cell-cytometric image analysis approaches. Statistical treatments were also implemented to analyze intra-population variability.


RESULTS
Our results demonstrate that the high-throughput fluorometric assay using 2-NBDG is a reliable method to assess population-level kinetics of glucose uptake in cell lines in vitro. Similarly, single-cell image-based assays and analyses of 2-NBDG fluorescence proved an effective and accurate means for assessing glucose uptake, which revealed that breast tumor cell lines display intra-population variability that is modulated by growth conditions.


CONCLUSIONS
These studies indicate that 2-NBDG can be used to aid in the high-throughput analysis of the influence of chemotherapeutics on glucose uptake in cancer cells.
Hassanein
Mohamed
M
Vanderbilt Integrative Cancer Biology Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Weidow
Brandy
B
Koehler
Elizabeth
E
Bakane
Naimish
N
Garbett
Shawn
S
Shyr
Yu
Y
Quaranta
Vito
V
D045744:Cell Line, Tumor; D005453:Fluorescence; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D009369:Neoplasms / Q000378:metabolism*
D005947:Glucose
Glia. 2009 Jul;57(9):962-70
19062182
Biochem J. 1988 Oct 15;255(2):750-1
3202844
Clin Nucl Med. 2000 Nov;25(11):874-81
11079583
Nat Protoc. 2007;2(3):753-62
17406637
Biosens Bioelectron. 2004 Oct 15;20(3):643-50
15494250
Nat Clin Pract Oncol. 2008 Sep;5(9):512-20
18594499
Curr Opin Genet Dev. 2008 Feb;18(1):54-61
18387799
Appl Microbiol Biotechnol. 1996 Nov;46(4):400-4
8987729
J Nucl Med. 2008 Dec;49(12):1973-9
18997052
Annu Rev Med. 2002;53:89-112
11818465
Breast Cancer Res Treat. 2008 Jul;110(2):297-307
17879159
J Neurochem. 2009 May;109 Suppl 1:94-100
19393014
J Membr Biol. 1978 Apr 20;40(1):67-76
650675
Glycoconj J. 2008 Aug;25(6):503-10
17973187
Science. 1956 Feb 24;123(3191):309-14
13298683
Physiol Res. 1999;48(6):401-10
10783904
Cell. 2008 Sep 5;134(5):703-7
18775299
J Neurosci. 2004 Oct 27;24(43):9669-73
15509754
Biosci Biotechnol Biochem. 1996 Nov;60(11):1899-901
8987871
Int J Cancer. 2009 Jun 1;124(11):2634-42
19173294
Curr Protoc Mol Biol. 2008 Apr;Chapter 14:Unit 14.17
18425761
J Biomed Opt. 2009 Nov-Dec;14(6):064014
20059252
Microvasc Res. 2008 Jan;75(1):73-82
17531273
Nature. 2008 Mar 13;452(7184):230-3
18337823
J Natl Cancer Inst. 1977 Nov;59(5):1357-67
71356
Science. 1982 Jan 8;215(4529):127-34
7053564
Cancer Lett. 1997 Nov 11;119(2):207-12
9570373
Cytometry A. 2005 Mar;64(1):27-33
15688355
Metab Eng. 1999 Oct;1(4):320-33
10937825
J Neurosci. 2003 Aug 13;23(19):7337-42
12917367
Bioconjug Chem. 2006 May-Jun;17(3):662-9
16704203
Mol Imaging Biol. 2005 Nov-Dec;7(6):388-92
16284704
BMC Bioinformatics. 2008 Nov 15;9:482
19014601
Pflugers Arch. 2001 Nov;443(2):234-9
11713649
Science. 2009 May 22;324(5930):1029-33
19460998
J Clin Invest. 2008 Dec;118(12):3930-42
19033663
Methods Enzymol. 2009;467:23-57
19897088
Clin Cancer Res. 2007 Jun 15;13(12):3460-9
17575208
Carcinogenesis. 2009 Aug;30(8):1269-80
19321800
J Biochem Biophys Methods. 2005 Sep 30;64(3):207-15
16182371
Ann N Y Acad Sci. 2009 Aug;1171:479-83
19723092
Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1339-47
17333178
Eur J Cancer Prev. 1993 Nov;2 Suppl 3:67-76
7507749
Cell. 2000 Jan 7;100(1):57-70
10647931
Science. 1956 Aug 10;124(3215):269-70
13351639
Biochim Biophys Acta. 1996 Feb 9;1289(1):5-9
8605231
J Biol Chem. 2000 Jul 21;275(29):22278-83
10748091
Eur J Nucl Med. 2000 Sep;27(9):1305-11
11007511
Genes Dev. 2009 Mar 1;23(5):537-48
19270154
In Vitro Cell Dev Biol. 1989 Mar;25(3 Pt 1):267-75
2466823